1. Home
  2. SINT vs SNGX Comparison

SINT vs SNGX Comparison

Compare SINT & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.82

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.41

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
SNGX
Founded
1996
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
11.2M
IPO Year
2007
2006

Fundamental Metrics

Financial Performance
Metric
SINT
SNGX
Price
$2.82
$1.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.00
$6.00
AVG Volume (30 Days)
23.8K
222.1K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
57.03
EPS
N/A
N/A
Revenue
$1,018,000.00
$119,371.00
Revenue This Year
$30.26
N/A
Revenue Next Year
$413.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.79
$1.00
52 Week High
$6.78
$6.23

Technical Indicators

Market Signals
Indicator
SINT
SNGX
Relative Strength Index (RSI) 52.36 73.76
Support Level $2.60 $1.19
Resistance Level $2.97 $1.47
Average True Range (ATR) 0.16 0.06
MACD 0.03 0.03
Stochastic Oscillator 55.96 87.88

Price Performance

Historical Comparison
SINT
SNGX

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: